ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,374.00
0.89%
S&P ASX All Technology
3,896.40
2.69%
Brent Oil
72.625
-0.43%
US Dollar vs AUD
1.53744
0.04%
Bitcoin
92,058.37
1.67%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT

  6. Philogen Spa (PHIL) Share Price

Philogen Spa

Philogen Spa (PHIL)

Pacific Horizon Investment Trust PLC
Pacific Horizon Investment Trust PLC
Pacific Horizon Investment Trust PLC
PHI Group Inc (PK)
19.75
-0.25
( -1.25% )
Updated: 02:01:02
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
19.75
Bid
19.65
Offer
19.85
Volume
3,437
19.75 Day's Range 20.00
16.30 52 Week Range 21.90
Market Cap
797.853M
Previous Close
20.00
Open
19.90
Last Trade
68
@
19.75
Last Trade Time
02:01:02
Financial Volume
-
VWAP
-
Average Volume (3m)
8,194
Shares Outstanding
40,397,605
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
25.12M
Net Profit
-6.16M

About Philogen Spa

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.philogen.com
Headquarters
Siena, Siena, Ita
Founded
-
Philogen Spa is listed in the Pharmaceutical Preparations sector of the Italian Stock Exchange with ticker PHIL. The last closing price for Philogen was 20.00 €. Over the last year, Philogen shares have traded in a share price range of 16.30 € to 21.90 €.

Philogen currently has 40,397,605 shares in issue. The market capitalisation of Philogen is 807.95 € million.

Ask ADVFN Intelligence (AI)

PHIL Latest News

More News

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue...

20 February 2024
GlobeNewswire Inc.

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities SIENA, Italy, Dec. 05, 2023...

05 December 2023
GlobeNewswire Inc.

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors Novel...

04 December 2023
GlobeNewswire Inc.

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

Intratumoral Nidlegy™ followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alone PIVOTAL (NCT02938299) is the first and so far only Phase III trial...

16 October 2023
GlobeNewswire Inc.

Philogen Announces Clinical Trial Collaboration with MSD

Philogen Announces Clinical Trial Collaboration with MSD The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy™ in combination with...

01 June 2023
GlobeNewswire Inc.

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand Mumbai...

30 May 2023
GlobeNewswire Inc.

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich Philogen Publishes New Data on a...

25 May 2023
GlobeNewswire Inc.

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology Philogen Announces Publication...

28 March 2023
GlobeNewswire Inc.

Philogen Provides Corporate Update

Philogen Provides Corporate Update Philogen Provides Corporate Update Nidlegy™ and Fibromun pivotal clinical trials on track Fibromun shows potent activity in last-line glioblastoma in...

01 December 2022
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.45-2.2277227722820.220.519.51055019.57365029DE
4-0.35-1.7412935323420.120.719.5458119.80862466DE
12-1.65-7.7102803738321.421.619.3819420.04729673DE
261.659.1160220994518.121.917.6828220.29732796DE
521.79.4182825484818.0521.916.31071318.84194993DE
1565.4337.918994413414.3221.913903116.65209301DE
2602.7516.17647058821721.912.61231015.98268592DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
1SMCISuper Micro Computer Inc
25.92 €
(30.51%)
33.97k
WGML25GM Leather spa
0.0139 €
(26.36%)
10k
SIFSif Italia Spa
1.48 €
(19.35%)
14k
1TKAThyssenkrupp AG
3.80 €
(11.90%)
153.6k
WEXE26Execus SpA
0.16 €
(9.59%)
5k
1NKLANikola Corp
1.85 €
(-30.04%)
36.72k
WLDB24Lindbergh Spa
0.44 €
(-22.25%)
52.01k
WUBM26Ulisse BioMed SpA
0.137 €
(-21.71%)
2k
1SPCEVirgin Galactic Holdings Inc
6.40 €
(-17.95%)
650
WSGC28SG Company SpA
0.025 €
(-16.11%)
7.54k
TITTelecom Italia SpA
0.2286 €
(-4.31%)
163.08M
ISPIntesa Sanpaolo Spa
3.6605 €
(-2.54%)
65.99M
SPMSaipem Spa
2.318 €
(-2.11%)
24.11M
ENELEnel Spa
6.594 €
(-1.57%)
21.04M
TITRTelecom Italia
0.2716 €
(-4.10%)
20.39M

Discussion

View Full Feed
pochemunyet pochemunyet 3 minutes ago
Or KCC knows something and is lying low.
LWLG
Trooperstocks Trooperstocks 4 minutes ago
$PWM News! Prestige Wealth Inc. Announces Acquisitions of InnoSphere Tech and Closing of Acquisition of Wealth AI
Rhea-AI Summary
Prestige Wealth (NASDAQ: PWM) has announced two significant acquisitions to strengthen its AI and wealth management capabilities. The company will acquire I
PWM
TenKay TenKay 4 minutes ago
Remember Lucy and the football…
VERB
meshcan meshcan 4 minutes ago
Thanks for all DD Winechemist! My favorite section is this:

" style="color: rgba(29, 38, 46, 1); font-size: 15px"Elite with have at a minimum 2-3 year head start over anyone trying to switch."
style="color: rgba(29, 38, 46, 1); font-size: 15px"

style=
ELTP
ORCA ORCA 4 minutes ago
THEY PUMPED THE NEWS GARBAGE AND DID NOT DELIVER.SCAM.GLAD I WAS SELLING.I NEVER TRUST THIS ABSOLUTE POS OTIKO.
VDRM
highstakes highstakes 4 minutes ago
When is this zoom call? I'm wondering.


Dksc
DKSC
Rodney5 Rodney5 4 minutes ago
Former FHFA Director Calabria said, “stripping all net value long after Fannie and Freddie has been repaid when HERA, and precedent, limit this recovery to the funding actually provided.”

Calabria in plan language admitting to Federal Statutes and turns from the very Statute he wrote
FNMA
Killmaril Killmaril 4 minutes ago
You can buy this garbage in a hurry. The Ceo is a liar, creates shares like crazy and is still not ashamed to lie to shareholders. Outright lying. This is how we look at 003 soon... Otherwise 0.0000 per share is still zero. Buy as many wallpapers as you can.
CYBL
Methinks Methinks 5 minutes ago
https://www.scworld.com/brief/cyberattack-pilfers-250k-from-ilearningengines
They are still stealing from our kids! Get Wave.
Debunkinator Debunkinator 5 minutes ago
It would be nice to be at 0.001 plus before the next hammer drops.
ASII
I am done I am done 5 minutes ago
$HRAL Hear At Last Holdings, Has Contracted with Canadian Heritage to Manage the Installation of Their Hohm Sales
https://www.newsfilecorp.com/release/230469/Hear-At-Last-Holdings-HRAL-Has-Contracted-with-Canadian-Heritage-to-Manage-the-Installation-of-Their-Hohm-Sales
HRAL
srinsocal srinsocal 5 minutes ago
I will save you the angst of waiting until 2025

The $16 million in loans will not be paid off in 2024. The lenders who hold these loans, most held by the CEO and the COB, have extended their loans many times and will continue to do so as BIEL becomes profitable.
BIEL
resx18 resx18 5 minutes ago
$CBDW signed a Letter of Intent (LOI) with Adnexus Biotechnologies, a leading firm in AI and biotechnology solutions. This potential strategic investment underscores our commitment to expanding our technological footprint and enhancing our capabilities in the rapidly evolving field of AI. We believe
CBDW
mzasif mzasif 5 minutes ago
But that is A/S at 2B, not O/S (499m)...what am I missing?
BNCM
I am done I am done 5 minutes ago
$HRAL Hear At Last Holdings, Has Contracted with Canadian Heritage to Manage the Installation of Their Hohm Sales
https://www.newsfilecorp.com/release/230469/Hear-At-Last-Holdings-HRAL-Has-Contracted-with-Canadian-Heritage-to-Manage-the-Installation-of-Their-Hohm-Sales
HRAL
Wayne R Wayne R 5 minutes ago
Dunno, looks like you were warned a couple times, doesn't really seem a bankable offense, I've seen worse.
Wayne R Wayne R 5 minutes ago
Dunno, looks like you were warned a couple times, doesn't really seem a bankable offense, I've seen worse.
GBR GBR 5 minutes ago
That recent aiWARE article refers to "agentic AI".


It also positions Veritone to support the emerging Agentic AI trend, where autonomous AI agents act independently based on predefined parameters. Because aiWARE is inherently event-driven, developers can easily set up AI agent
VERI
martyDg martyDg 6 minutes ago
Well, I wonder when that magistrate ever decides 2025 or 2026?
NWBO
fliegenfranz1 fliegenfranz1 6 minutes ago
they have been.doing.that.since day 1.....when confronted ....they lie...again and again....criminal scam
AXXA
Trooperstocks Trooperstocks 6 minutes ago
Good morning $PWM
PWM
novicetrader novicetrader 6 minutes ago
LUNR-you still in? Up 10% today.What is your target on this one?
LUNR
slops slops 6 minutes ago
That's right no FLUFF just the FACTS
VDRM

Your Recent History

BIT
PHIL
Philogen
BIT
P1W4B5
NLBNPIT1W4B5 20991231 34...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved